Mills J W, Falsig Pedersen S, Walmod P S, Hoffmann E K
Department of Biology, Clarkson University, Potsdam, New York 13699, USA.
Exp Cell Res. 2000 Nov 25;261(1):209-19. doi: 10.1006/excr.2000.5032.
Cytochalasins have been used extensively to probe the role of F-actin in different aspects of cellular function. Most of the data obtained are interpreted on the basis of the well-established depolymerizing effects of cytochalasins on F-actin preparations in vitro. However, some evidence indicates that, in intact cells, different cytochalasins can have varying effects on cell morphology and F-actin content and organization. To examine this problem in more detail, we analyzed the effects of cytochalasins on the cell morphology of and F-actin content and organization in Ehrlich ascites tumor (EAT) cells. After a 3-min exposure to 0.5 microM cytochalasin D, B, or E, F-actin content was equally reduced in all cases and this correlated with a reduction in the amount of cortical F-actin associated with the EAT cell membrane. However, only with CE was cell morphology markedly altered, with the appearance of numerous blebs. At 10 microM, blebbing was present in all conditions and the organization of cortical F-actin was disrupted. F-actin content, however, was not further reduced by this higher concentration and in CD it was identical to control levels. Exposure of EAT cells to similar concentrations of cheatoglobosin C, an analog of the cytochalasins that has little to no affinity for F-actin, resulted in a loss of F-actin content, a reduction in F-actin fluorescence, but no change in cell morphology, including a complete lack of bleb formation. Myosin II immunoreactivity, concentrated in the cortical cytoplasm colocalized with F-actin and in an area associated with the Golgi, was reduced by the high-dose cytochalasin. These results demonstrate that caution must be exercised in the use of cytochalasins to probe the role of F-actin in cellular function and that several parameters must be analyzed to obtain an accurate assessment of the effect of cytochalasin on the actin filament system.
细胞松弛素已被广泛用于探究F-肌动蛋白在细胞功能不同方面的作用。所获得的大多数数据都是基于细胞松弛素对体外F-肌动蛋白制剂的既定解聚作用来解释的。然而,一些证据表明,在完整细胞中,不同的细胞松弛素对细胞形态、F-肌动蛋白含量和组织可能有不同的影响。为了更详细地研究这个问题,我们分析了细胞松弛素对艾氏腹水瘤(EAT)细胞的细胞形态、F-肌动蛋白含量和组织的影响。在暴露于0.5微摩尔细胞松弛素D、B或E 3分钟后,所有情况下F-肌动蛋白含量均同等降低,这与EAT细胞膜相关的皮质F-肌动蛋白量的减少相关。然而,只有细胞松弛素E使细胞形态发生明显改变,出现大量泡状突起。在10微摩尔时,所有条件下均出现泡状突起,皮质F-肌动蛋白的组织被破坏。然而,这种较高浓度并未使F-肌动蛋白含量进一步降低,在细胞松弛素D处理组中其与对照水平相同。将EAT细胞暴露于类似浓度的欺骗球囊霉素C(一种对F-肌动蛋白几乎没有或没有亲和力的细胞松弛素类似物),导致F-肌动蛋白含量丧失、F-肌动蛋白荧光降低,但细胞形态没有变化,包括完全没有泡状突起形成。高剂量细胞松弛素使集中在皮质细胞质中与F-肌动蛋白共定位且与高尔基体相关区域的肌球蛋白II免疫反应性降低。这些结果表明,在使用细胞松弛素探究F-肌动蛋白在细胞功能中的作用时必须谨慎,并且必须分析几个参数才能准确评估细胞松弛素对肌动蛋白丝系统的影响。